JWH-018 and JWH-073 Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Products containing naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) and naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) are emerging drugs of abuse. Here, the behavioral effects of JWH-018 and JWH-073 were examined in one behavioral assay selective for cannabinoid agonism, rhesus monkeys (n 4) discriminating Δ⁹-tetrahydrocannabinol (Δ⁹-THC 0.1 mgkg i.v.), and another assay sensitive to cannabinoid withdrawal, i.e., monkeys (n 3) discriminating the cannabinoid antagonist rimonabant (1 mgkg i.v.) during chronic Δ⁹-THC (1 mgkg s.c. 12 h) treatment. Δ⁹-THC, JWH-018, and JWH-073 increased drug-lever responding in monkeys discriminating Δ⁹-THC the ED₅₀ values were 0.044, 0.013, and 0.058 mgkg, respectively and the duration of action was 4, 2, and 1 h, respectively. Rimonabant (0.32-3.2 mgkg) produced surmountable antagonism of Δ⁹-THC, JWH-018, and JWH-073. Schild analyses and single-dose apparent affinity estimates yielded apparent pA₂pK(B) values of 6.65, 6.68, and 6.79 in the presence of Δ⁹-THC, JWH-018, and JWH-073, respectively. In Δ⁹-THC-treated monkeys discriminating rimonabant, the training drug increased responding on the rimonabant lever the ED₅₀ value of rimonabant was 0.20 mgkg. Δ⁹-THC (1-10 mgkg), JWH-018 (0.32-3.2 mgkg), and JWH-073 (3.2-32 mgkg) dose-dependently attenuated the rimonabant-discriminative stimulus (i.e., withdrawal). These results suggest that Δ⁹-THC, JWH-018, and JWH-073 act through the same receptors to produce Δ⁹-THC-like subjective effects and attenuate Δ⁹-THC withdrawal. The relatively short duration of action of JWH-018 and JWH-073 might lead to more frequent use, which could strengthen habitual use by increasing the frequency of stimulus-outcome pairings. This coupled with the possible greater efficacy of JWH-018 at cannabinoid 1 receptors could be associated with greater dependence liability than Δ⁹-THC.